(REGN) Regeneron - Performance -47.3% in 12m
REGN performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-6.83%
#36 in Peer-Group
Rel. Strength
10.19%
#6882 in Stock-Universe
Total Return 12m
-47.30%
#123 in Peer-Group
Total Return 5y
-7.56%
#37 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 13.9 |
| P/E Forward | 15.5 |
| High / Low | USD |
|---|---|
| 52 Week High | 1198.45 USD |
| 52 Week Low | 483.07 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 89.09 |
| Buy/Sell Signal +-5 | 1.35 |
| Support / Resistance | Levels |
|---|---|
| Support | 524.6 |
| Resistance | 733.5, 604.7 |
12m Total Return: REGN (-47.3%) vs XBI (-11.1%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
1.02% | 61.8% | 74.7% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
6.89% | -8.76% | 155% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
1.19% | -6.24% | 38% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-2.29% | 26.9% | -2.56% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
7.48% | -8.9% | 5.85% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
11.5% | 27.6% | -6.21% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.47% | 46.2% | -8.05% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.64% | 26.9% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: REGN vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for REGN
| Total Return (including Dividends) | REGN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 9.48% | 3.15% | 4.01% |
| 3 Months | 2.60% | 17.08% | 17.14% |
| 12 Months | -47.30% | -11.14% | 13.46% |
| 5 Years | -7.56% | -21.96% | 112.73% |
| Trend Score (consistency of price movement) | REGN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 77.8% | 52.1% | 90.3% |
| 3 Months | -51.1% | 79.4% | 97.5% |
| 12 Months | -96.6% | -87.4% | 46.4% |
| 5 Years | 62.2% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th72.00 | 6.13% | 5.25% |
| 3 Month | %th29.50 | -12.37% | -12.42% |
| 12 Month | %th39.00 | -40.69% | -53.55% |
| 5 Years | %th81.50 | 18.45% | -56.55% |
FAQs
Does Regeneron (REGN) outperform the market?
No,
over the last 12 months REGN made -47.30%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.14%.
Over the last 3 months REGN made 2.60%, while XBI made 17.08%.
Performance Comparison REGN vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
REGN vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 5% | 5.5% | -28.5% | -61% |
| US NASDAQ 100 | QQQ | 5.1% | 5.3% | -30.5% | -61% |
| German DAX 40 | DAX | 4.7% | 8.3% | -40.6% | -78% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 3.9% | 4.9% | -32.9% | -66% |
| Hongkong Hang Seng | HSI | 4.2% | 6.7% | -50.5% | -82% |
| India NIFTY 50 | INDA | 6.4% | 10.3% | -28.9% | -44% |
| Brasil Bovespa | EWZ | 9.3% | 10.1% | -43.5% | -49% |
REGN vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 6.4% | 7.8% | -31.8% | -71% |
| Consumer Discretionary | XLY | 4.1% | 6.1% | -20.8% | -65% |
| Consumer Staples | XLP | 7.1% | 9.6% | -27.6% | -55% |
| Energy | XLE | 2.1% | 5.4% | -20.9% | -49% |
| Financial | XLF | 6.5% | 6.9% | -30.8% | -73% |
| Health Care | XLV | 4.9% | 9.4% | -17% | -41% |
| Industrial | XLI | 4.6% | 5% | -34.3% | -71% |
| Materials | XLB | 4.4% | 5% | -29.1% | -51% |
| Real Estate | XLRE | 5.3% | 9.6% | -27% | -56% |
| Technology | XLK | 5.2% | 2.9% | -33.6% | -58% |
| Utilities | XLU | 5% | 6.9% | -32.5% | -67% |
| Aerospace & Defense | XAR | 4.4% | 2.6% | -48.5% | -96% |
| Biotech | XBI | 1.4% | 6.3% | -18.2% | -36% |
| Homebuilder | XHB | 2% | 0.7% | -21.9% | -46% |
| Retail | XRT | 5.1% | 6.2% | -23.7% | -54% |
REGN vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 4.5% | 6.18% | -14.6% | -43% |
| Natural Gas | UNG | 6.8% | 15.9% | -2.5% | -45% |
| Gold | GLD | 4.9% | 9.2% | -46.4% | -86% |
| Silver | SLV | 0.7% | 3.2% | -50.5% | -69% |
| Copper | CPER | -5.3% | -5.5% | -48% | -71% |
REGN vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 5.9% | 9.5% | -23.2% | -43% |
| iShares High Yield Corp. Bond | HYG | 5.6% | 8.4% | -25.5% | -56% |